LFG
HAE icon

Larson Financial Group’s Haemonetics HAE Stock Holding History

Larson Financial Group’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-22
Closed -$1.4K – 3373
2025
Q1 		$1.4K Buy
+22
New +$1.5K ﹤0.01% 2285

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Larson Financial Group's HAE Position: Q2 2025 in Review

Larson Financial Group sold out of Haemonetics (HAE) in Q2 2025, closing a stake of 22 shares — an estimated $1.4K sold.

Larson Financial Group first reported a position in HAE in Q1 2025 and held it in 1 quarter. The position peaked at $1.4K in Q1 2025. 298 funds tracked by Wall St. Rank hold HAE as of Q2 2025.

  • Larson Financial Group reported no remaining Haemonetics position as of Q2 2025 after selling out during the quarter.
  • Larson Financial Group sold 22 Haemonetics shares in Q2 2025, an estimated $1.4K.
  • Larson Financial Group first reported a position in Haemonetics in Q1 2025 and held it in 1 quarter.
  • Larson Financial Group's Haemonetics position peaked at $1.4K in Q1 2025.
  • 298 funds tracked by Wall St. Rank held Haemonetics as of Q2 2025.

Based on Larson Financial Group's 13F filing for Q2 2025, filed 8 Aug 2025.